David A. Hall, Chief Revenue Officer at Hill Research, Co-Founder and CEO at TAMP, shared on LinkedIn:
“I’m honored to join the panel on AI and Cancer Detection at the National Foundation for Cancer Research (NFCR) Global Summit and Award Ceremonies on Friday, October 9, at the National Press Club in Washington, DC.
The program brings together an extraordinary group, starting with a keynote from Bruce Beutler, 2011 Nobel Laureate in Physiology or Medicine, and a featured talk from Doug Lowy, Deputy Director of National Cancer Institute (NCI), on the latest clinical results in preventing HPV-associated cancers.
I’m grateful to share the stage on our panel with:
- Olufunmilayo (Funmi) Olopade, Loyola University Chicago Stritch School of Medicine (moderator)
- Bill Lotter, Dana-Farber Cancer Institute
- Shweta Maniar, Google Cloud
- Eytan Ruppinn, Cedars-Sinai Medical Center
AI in cancer detection has moved fast in the lab. The harder question now is what it takes to move a promising model into routine care:
The evidence regulators need, results that can be reproduced years later, workflows clinicians will actually use, and access for the communities that are diagnosed latest. That’s the part of the conversation I’m looking forward to.
Thank you to Sujuan Ba and the NFCR team for the invitation, and for decades of work funding the science that makes days like this possible. The day ends with the Lara Szent-Gyorgyi Prize honoring Dr. Michele Carbone.
If you’ll be in DC on October 9, I’d welcome the chance to connect.”
You can also read :
AI Analysis of Routine MRI Scans Links Muscle And Body Fat to Outcomes for Multiple Myeloma Patients
